Impact of advance directives on the variability between intensivists in the decisions to forgo life-sustaining treatment.
Margot SmirdecMercé JourdainVirginie GuastellaCéline LambertJean-Christophe RichardLaurent ArgaudSamir JaberKada KloucheAnne MedardJean ReignierJean-Philippe RigaudJean-Marc DoiseRussell ChabanneBertrand SouweineJeremy BourenneJulie DelmasPierre-Marie BertrandPhilippe VerdierJean-Pierre QuenotCecile AubronNathanael EisenmannPierre AsfarAlexandre FrataniJean DellamonicaNicolas TerziJean-Michel ConstantinAxelle Van LanderRenaud GuerinBruno PereiraAlexandre LautrettePublished in: Critical care (London, England) (2020)
ADs increased the DFLST rate but did not reduce variability between the intensivists. In the decision-making process using ADs, the intensivist's decision took priority. Further research is needed to improve the matching of the physicians' decision with the patient's wishes. Trial registration ClinicalTrials.gov Identifier: NCT03013530. Registered 6 January 2017; https://clinicaltrials.gov/ct2/show/NCT03013530 .